Product Spotlight: Automation/IT/Process Control - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Product Spotlight: Automation/IT/Process Control
New product reviews for March 2013, featuring automation, IT, and process control systems.

Pharmaceutical Technology
Volume 37, Issue 3, pp. 16

Editors' Picks of Pharmaceutical Science & Technology Innovations

THE LATEST IN AUTOMATION/IT/PROCESS CONTROL

Dynamic light scattering system measures microrheology and protein structure



The Zetasizer Nano ZSP is an addition to the Malvern Instruments' range of dynamic light scattering (DLS) systems. The Nano ZSP measures both size and zeta potential (i.e., electrophoretic mobility) of proteins. A new protein mobility measurement type in the software that controls data acquisition guides the user through the measurement and assesses and reports on data quality. The Nano ZSP uses a new version of Zetasizer software that enables microrheology measurements for the first time on Zetasizer instruments. This DLS-based optical technique allows rheological characterization of weakly-structured and highly strain-sensitive materials using only microliter-sample volumes.

Malvern Instruments
http://www.malvern.com/
Systems are available worldwide

Updated process optimization software offers usability enhancements



The latest version of Aspen Technology's aspenONE software (V8) provides new functionality, and usability and visualization enhancements. For manufacturing and supply chain purposes, the software features adaptive process control, which automates many tasks and makes maintenance a continuous process. The software also includes the company's Aspen Collaborative Demand Manager, which provides information to help manage different forecasting requirements. Other features include energy and economic analysis and solids modeing functionality.

Aspen Technology, Inc.
http://www.aspentech.com/
Software is available worldwide

iPad app for mass spectrometry applications



The Overlap Evaluator iPad app from Hiden Analytical is a reference tool for users of mass spectrometers operating in the fields of vacuum science and vacuum processing, and for research involving real-time gas-analysis systems. The evaluator enables the user to create a mass spectral overview of multiple fragmentation spectra to identify the mass peaks with least spectral interference, and therefore, most suited to species monitoring, and includes a quick mass peak look up table from a library of common gas and vapor species.

Hiden Analytical
http://www.hidenanalytical.com/
App is available worldwide

Technology offers nucleation process control in freeze drying



SP Scientific's ControLyo Nucleation On-Demand Technology can be retrofitted to range of previously installed production freeze dryers and can help to make the freezing step more repeatable. The random nature of nucleation has often prevented the freezing step of lyophilization from being controlled, but SP Scientific's technology helps to regulate the nucleation temperature. As well as offering greater control over cycle optimization, the technology can also help improve vial-to-vial uniformity, reduce cycle times, reduce protein aggregation and enable easier process scale-up. In addition, the technology can help lyophilization processes to adhere to process analytical technology and quality-by-design initiatives.

SP Scientific
http://www.spscientific.com/
Contact company for details of availability

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here